Striking study results last year indicated a new type of medicine may improve on Merck’s immunotherapy, spurring a wave of ...

The antibody has shown promising results in preclinical studies, demonstrating 'superior' anti-tumour activity.

Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...

Yet there has been no clear molecular explanation for such diversity at the level of vascular endothelial growth factor A (VEGF-A) and other established regulators of angiogenesis that are ...

Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal ...

VEGF165 is the most abundant splice variant of VEGF-A and is produced by various cell types, including endothelial cells, macrophages, and T cells. It plays a critical role in angiogenesis ...

DUBLIN--(BUSINESS WIRE)--The "PD-1 x VEGF and PD-L1 x VEGF Bispecific Antibodies: A Business, Pipeline And Competitor Analysis From An Industry Perspective" report has been added to ...

Physicians’ Education Resource (PER) has launched Retina Resource, a comprehensive source of education and information on the ...

Physicians’ Education Resource (PER ®) is excited to announce the launch of Retina Resource, a comprehensive source of cutting-edge education and information on the latest innovations in anti-VEGF ...

Anti-VEGF therapy improves outcomes in retinal diseases by targeting neovascularization and macular edema, crucial in conditions like AMD and diabetic retinopathy. Optical coherence tomography is ...